Niva Bupa Health Insurance Company Limited (BOM:544286)
India · Delayed Price · Currency is INR | Market Cap | 156.14B +0.4% |
| Revenue (ttm) | 84.43B +33.4% |
| Net Income | 3.66B +80.5% |
| EPS | 1.98 +73.7% |
| Shares Out | n/a |
| PE Ratio | 42.64 |
| Forward PE | 76.77 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 182,167 |
| Open | 84.63 |
| Previous Close | 83.57 |
| Day's Range | 83.29 - 85.00 |
| 52-Week Range | 67.50 - 94.00 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 91.10 (+7.94%) |
| Earnings Date | May 8, 2026 |
About BOM:544286
Niva Bupa Health Insurance Company Limited provides health insurance products in India. It offers health insurance plans, such as individual, family, NRIs, senior citizens, personal accident, critical illness; travel insurance, including international and studying abroad insurance plans; and corporate insurance comprising group and start up health, group personal accident and OPD coverage, and group health insurance claim process. The company was formerly known as Max Bupa Health Insurance Company Limited and changed its name to Niva Bupa Healt... [Read more]
Financial Performance
In fiscal year 2026, BOM:544286's revenue was 84.43 billion, an increase of 33.38% compared to the previous year's 63.30 billion. Earnings were 3.66 billion, an increase of 80.45%.
Financial StatementsNews
Niva Bupa Health Insurance Company Transcript: Q4 25/26
Reported 27.4% GWP growth and 80% profit increase for FY 2026, with improved combined and expense ratios. Retail health market share rose to 10.1%, and digital, distribution, and regulatory initiatives are driving future growth.
Niva Bupa Health Insurance Company Quarterly report: Q4 2026
Niva Bupa Health Insurance Company has published its Q4 2026 quarterly earnings report on May 8, 2026.
Niva Bupa Health Insurance Company Slides: Q4 2026
Niva Bupa Health Insurance Company has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 8, 2026.
Niva Bupa Health Insurance Company Transcript: Q3 25/26
Nine-month PAT rose 74% year-over-year to INR 208 crore, with overall growth at 26% and retail at 33%. Q3 saw strong new business and digital channel growth, improved combined and expense ratios, and positive GST tailwinds. Industry initiatives and regulatory clarity support sustained performance.
Niva Bupa Health Insurance Company Quarterly report: Q3 2026
Niva Bupa Health Insurance Company has published its Q3 2026 quarterly earnings report on January 29, 2026.
Niva Bupa Health Insurance Company Slides: Q3 2026
Niva Bupa Health Insurance Company has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on January 29, 2026.
Niva Bupa Health Insurance Company Transcript: Q2 25/26
H1 FY '26 saw 23% overall and 28% retail GWP growth, with PAT more than doubling year-over-year. GST reduction to 0% spurred over 50% retail growth in October, while combined and expense ratios improved. Group loss ratio rose due to mix, but retail remained stable.
Niva Bupa Health Insurance Company Quarterly report: Q2 2026
Niva Bupa Health Insurance Company has published its Q2 2026 quarterly earnings report on November 3, 2025.
Niva Bupa Health Insurance Company Slides: Q2 2026
Niva Bupa Health Insurance Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 3, 2025.
Niva Bupa Health Insurance Company Transcript: Q1 25/26
Q1 saw 28% YoY growth (32% in retail), with IFRS PAT nearly doubling to INR 70 crore and combined ratio improving to 103.2%. Loss ratios rose due to reserve increases and group mix, but expense ratios improved; volume growth drove premium gains. Key industry initiatives and tech upgrades support future outlook.
Niva Bupa Health Insurance Company Quarterly report: Q1 2026
Niva Bupa Health Insurance Company has published its Q1 2026 quarterly earnings report on July 31, 2025.
Niva Bupa Health Insurance Company Slides: Q1 2026
Niva Bupa Health Insurance Company has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on July 31, 2025.